Annual report
4526.TEDINET S100YFDJ
Period2025-04-01 → 2026-03-31
Filed2026-06-19
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥96.3bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥95.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥91.5bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥88.8bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥79.2bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥6.9bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥8.7bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥7.7bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥9.4bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥10.3bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥7.7bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.2bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥10.2bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥12.7bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥7.0bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥9.4bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥8.8bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥6.4bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥21.6bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥7.0bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥9.4bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥116.4bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥113.0bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥118.8bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥105.2bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥102.7bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥33.0bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥33.8bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥83.4bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥79.2bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥76.6bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥71.4bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥66.5bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥20.1bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥22.3bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥19.1bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥20.1bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥16.7bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥15.1bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥6.0bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥7.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥10.5bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥7.8bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥6.8bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥1.7bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥353m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥554m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.0bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.7bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥8.0bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥10.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥7.1bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥4.6bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥7.6bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥238.19 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥310.08 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥268.44 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥195.51 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥657.98 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,855.29 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,649.95 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,523.84 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,174.39 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,027.84 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 71.6% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.1% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.5% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.8% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.8% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 8.7% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.1% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.8% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.3% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 38.3% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,887 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 1,858 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 1,857 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 1,848 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 1,825 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥72.6bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥70.4bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥68.3bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥63.1bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥59.0bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥5.8bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥5.7bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥8.1bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥8.7bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥8.7bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.5bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.0bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥10.6bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥12.0bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥7.9bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥9.4bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥8.1bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥4.2bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥20.7bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥88.2bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥85.7bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥92.1bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥81.4bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥81.4bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥27.1bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥27.8bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥61.1bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥57.8bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥55.9bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥53.2bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥51.3bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥8.8bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥9.8bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥267.36 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥310.42 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥248.45 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥129.09 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥630.29 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥110 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥94 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥81 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥59 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥46 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,091.8 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,936.28 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,842.33 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,620.72 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,564.9 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 69.2% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.5% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.7% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.3% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.1% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 13.3% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.5% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.9% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.1% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 49.0% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 30,705,000 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 30,705,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 33,705,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 33,705,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,705,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,016 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 997 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 966 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 957 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 958 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 66
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2026-03-31 | −¥1.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2026-03-31 | −¥1.6bn |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | ¥28.3bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | ¥62m |
| Domestic Chemical Business And Othersreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥405m |
| Domestic Chemical Business And Othersreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥348m |
| Domestic Chemical Business And Othersreportable segment | employees | at 2026-03-31 | 123 pure |
| Domestic Chemical Business And Othersreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥8.7bn |
| Domestic Chemical Business And Othersreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥8.7bn |
| Domestic Chemical Business And Othersreportable segment | segment assets | at 2026-03-31 | ¥6.7bn |
| Domestic Chemical Business And Othersreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥857m |
| Domestic Food Businessreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥4.2bn |
| Domestic Food Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥3.5bn |
| Domestic Food Businessreportable segment | employees | at 2026-03-31 | 943 pure |
| Domestic Food Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥66.4bn |
| Domestic Food Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥66.4bn |
| Domestic Food Businessreportable segment | segment assets | at 2026-03-31 | ¥56.4bn |
| Domestic Food Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥6.4bn |
| Overseas Businessreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥2.0bn |
| Overseas Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥866m |
| Overseas Businessreportable segment | employees | at 2026-03-31 | 665 pure |
| Overseas Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥22.9bn |
| Overseas Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥21.3bn |
| Overseas Businessreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥1.6bn |
| Overseas Businessreportable segment | segment assets | at 2026-03-31 | ¥24.9bn |
| Overseas Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥436m |
| —segment total | capex | 2025-04-01 → 2026-03-31 | ¥6.6bn |
| —segment total | depreciation | 2025-04-01 → 2026-03-31 | ¥4.7bn |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥97.9bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥96.3bn |
| —segment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥1.6bn |
| —segment total | segment assets | at 2026-03-31 | ¥88.1bn |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥6.8bn |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥1.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥1.4bn |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥28.7bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | ¥49m |
| Domestic Chemical Business And Othersreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥359m |
| Domestic Chemical Business And Othersreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥290m |
| Domestic Chemical Business And Othersreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥8.0bn |
| Domestic Chemical Business And Othersreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥8.0bn |
| Domestic Chemical Business And Othersreportable segment | segment assets | at 2025-03-31 | ¥6.2bn |
| Domestic Chemical Business And Othersreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥895m |
| Domestic Food Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥2.6bn |
| Domestic Food Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥2.2bn |
| Domestic Food Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥64.8bn |
| Domestic Food Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥64.8bn |
| Domestic Food Businessreportable segment | segment assets | at 2025-03-31 | ¥53.9bn |
| Domestic Food Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥6.7bn |
| Overseas Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥2.3bn |
| Overseas Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥724m |
| Overseas Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥24.2bn |
| Overseas Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥22.8bn |
| Overseas Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥1.4bn |
| Overseas Businessreportable segment | segment assets | at 2025-03-31 | ¥24.1bn |
| Overseas Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥5.2bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥3.2bn |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥97.0bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥95.6bn |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥1.4bn |
| —segment total | segment assets | at 2025-03-31 | ¥84.3bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥8.7bn |
| Domestic Chemical Business And Othersreportable segment | employees | at 2026-03-31 | 89 pure |
| Domestic Food Businessreportable segment | employees | at 2026-03-31 | 746 pure |
| Overseas Businessreportable segment | employees | at 2026-03-31 | 25 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,072
| Item | Context | Value | Unit |
|---|---|---|---|
| Retirement benefit expenses sga | CurrentYearDuration_NonConsolidatedMember | -7000000 | JPY |
| Depreciation sga | Prior1YearDuration_NonConsolidatedMember | 219000000 | JPY |
| Depreciation sga | CurrentYearDuration_NonConsolidatedMember | 234000000 | JPY |
| Research and development expenses sga | Prior1YearDuration_NonConsolidatedMember | 2913000000 | JPY |
| Research and development expenses sga | CurrentYearDuration_NonConsolidatedMember | 3101000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)有価証券報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2026-06-19 | |
| Fiscal year cover page | FilingDateInstant | Original text (Japanese)第90期（自 2025年４月１日 至 2026年３月31日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)理研ビタミン株式会社 | |
| Company name in english cover page | FilingDateInstant | ＲＩＫＥＮ ＶＩＴＡＭＩＮ ＣＯ．，ＬＴＤ． | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 望月 敦 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都新宿区四谷一丁目６番１号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03（5362）1311（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)経理部長 小澤 出 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都新宿区四谷一丁目６番１号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03（5362）1311（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)経理部長 小澤 出 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E00952 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45260 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)理研ビタミン株式会社 | |
| Filer name in english | FilingDateInstant | RIKEN VITAMIN CO., LTD. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Current fiscal year start date | FilingDateInstant | 2025-04-01 | |
| Current period end date | FilingDateInstant | 2026-03-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2026-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2024-04-01 | |
| Comparative period end date | FilingDateInstant | 2025-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2025-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |